Automated phone and mail population outreach to promote colorectal cancer screening

American Journal of Managed Care

Volumn 18, Issue 7, 2012, Pages 370-378

  Kempe, Karin L ^a   Shetterly, Susan M ^b   France, Eric K ^a   Levin, Theodore R ^c  

^a Kaiser Permanente Colorado   (United States)

^b KAISER PERMANENTE   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; AUTOMATION; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; E-MAIL; FECES ANALYSIS; FEMALE; HEALTH INSURANCE; HEALTH PROGRAM; HISPANIC; HUMAN; IMMUNOHISTOCHEMISTRY; INTEGRATED HEALTH CARE SYSTEM; INTERACTIVE VOICE RESPONSE SYSTEM; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PATIENT CARE; POPULATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SMOKING;

AGED; COLORADO; COLORECTAL NEOPLASMS; COMMUNITY-INSTITUTIONAL RELATIONS; FEMALE; HEALTH PROMOTION; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT ACCEPTANCE OF HEALTH CARE; POSTAL SERVICE; PROPORTIONAL HAZARDS MODELS; REMINDER SYSTEMS; SURVIVAL ANALYSIS; TELEPHONE;

EID: 84865345134     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. US Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627-637.
2. Whitlock EP, Lin JS, Liles E, Bell TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U. S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):638-658.
3. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM; American College of Gastroenterology. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009;104(3):739-750.
4. Levin B, Lieberman DA, McFarland B, et al; American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee. Screening and surveillance for early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the U.S. Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterol. 2008;134(5):1570-1595.
5. Lieberman D. Progress and challenges in colorectal cancer screening and surveillance. Gastroenterol. 2010;138(6):2115-2126.
6. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy: the National Polyp Study Workgroup. N Engl J Med. 1993;329(27):1977-1981.
7. Atkin WS, Edwards R, Kralj-Hans I, et al; UK Flexible Sigmoidoscopy Trial Investigators. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicenter randomized controlled trial. Lancet. 2010;375(9726):1624-1633.
8. Hewitson P, Glasziou PP, Irwig L, Towler B, Watson E. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemocult): an update. Am J Gastroenterol. 2008;103(6): 1541-1549.
9. Neuget AI, Lebwohl B. Colonoscopy vs sigmoidoscopy screening: getting it right. JAMA. 2010;304(4):461-462.
10. Brenner H, Chang-Claude J, Seiler CM, Richert A, Hoffmeister M. Protection from colorectal cancer after colonoscopy. Ann Intern Med.2011;154(1):22-30.
11. Shavers VL, Jackson MC, Sheppard VB. Racial/ethnic patterns of uptake of colorectal screening, National Health Interview Survey 2000- 2008. J Natl Med Assoc. 2010;102(7):621-635.
12. Vital signs: colorectal cancer screening, incidence, and mortality - United States, 2002-2010. MMWR Morb Mortal Wkly Rep. 2011; 60 (26):884-889. Centers for Disease Control and Prevention website.http://www.cdc.gov/mmwr/ preview/mmwrhtml/mm6026a4.htm?s-cid=mm6026a4-w.
13. Hundt S, Haug U, Brenner H. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med. 2009;150(3):162-169.
14. Haug U, Hundt S, Brenner H. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests. Am J Gastroenterol. 2010;105(3):682-690.
15. Allison JE. FIT: a valuable but underutilized screening test for colorectal cancer-it's time for a change. Am J Gastroenterol. 2010; 105 (9):2026-2028.
16. Allison JE, Sakoda LC, Levin TR, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst. 2007;99(19):1462-1470.
17. Young GP, Cole SR. Which fecal occult blood test is best to screen for colorectal cancer [published online ahead of print January 27, 2009]? Nat Clin Pract Gastroenterol Hepatol. 2009;6(3):140-141.
18. Young GP, Cole SR. New stool screening tests for colorectal cancer [published online ahead of print October 19, 2007]. Digestion. 2007;76(1):26-33.
19. Oono Y, Iriguchi Y, Doi Y, et al. A retrospective study of immunochemical fecal occult blood testing for colorectal cancer detection [published online ahead of print February 23, 2010]. Clin Chim Acta. 2010;411(11-12):802-805.
20. Allison PD. Estimating Cox regression models with PROC PHREG. In: Survival Analysis Using the SAS System: A Practical Guide. Gary, NC: SAS Institute Inc; 1995.
21. Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011;33(1):101-110.
22. Steinwachs D, Allen JD, Barlow WE, et al. National Institutes of Health State-of-the-Science Conference Statement: enhancing the use and quality of colorectal cancer screening. Ann Intern Med. 2010;152(10): 668-676.
23. Holden DJ, Jonas DE, Portereld DS, Reuland D, Harris R. Systematic review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med. 2010;152(10):668-676.
24. Hoffman RM, Steel S, Yee EFT, Massie L, Schrader RM, Murata GH. Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized controlled trial. Prev Med. 2010;50(5-6):297-299.
25. Van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterol. 2008;135(1):82-90.
26. Hol L, van Leerdam ME, Ballegooijen M, et al. Screening for colorectal cancer: randomized trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut. 2010;59(1):62-68.
27. Park D, Ryu S, Kim YH, et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol. 2010;105(9):2017- 2025.
28. Levin TR. Optimizing colorectal cancer screening by getting FIT right.Gastroenterol. 2011;141(5):1551-1555.
29. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):659-669.
30. Parekh M, Fendrick AM, Ladabaum U. As tests evolve and costs of cancer care rise: reappraising stool-based screening for colonic neoplasia. Aliment Pharmacol Ther. 2008;27(8):697-712.
31. Simon SR, Zhang F, Soumerai SB, et al. Failure of automated telephone outreach with speech recognition to improve colorectal cancer screening. Arch Intern Med. 2010;170(3):264-270.
32. Constanza ME, Luckmann R, Stoddard AM, et al. Using tailored telephone counseling to accelerate the adoption of colorectal cancer screening [published online ahead of print July 23, 2007]. Cancer Detect Prev. 2007;31(3):191-198.
33. Mosen DM, Feldstein AC, Perrin N, et al. Automated telephone calls improved completion of fecal occult blood testing. Med Care. 2010;48(7):604-610.
34. Denberg TD, Myers BA, Lin CT, Levine J. Screening colonoscopy through telephone outreach without antecedent provider visits: a pilot study. Prev Med. 2009(48):91-93.
35. Daly JM, Levy BT, Merchant ML, Wilbur J. Mailed fecal-immunochemical test for colon cancer screening. J Community Health. 2010; 35 (3):235-239.
36. Hawley ST, Volk RJ, Krishnamurthy P, Jibaja-Weiss M, Vernon SW, Kneuper S. Preferences for colorectal cancer screening among racially/ ethnically diverse primary care patients. Med Care. 2008;46(9): S10-S16.
37. Schenck AP, Klabunde CN, Davis WW. Racial differences in colorectal cancer test use by Medicare consumers. Am J Prev Med. 2006;30 (4):320-326.
38. Shokar NK, Carlson CA, Weller SC. Prevalence of colorectal cancer testing and screening in a multiethnic primary care population. J Community Health. 2007;32(5)311-323.
39. Harden E, Moore A, Melvin C. Exploring perceptions of colorectal cancer and fecal immunochemical testing among African Americans in a North Carolina community. Prev Chronic Dis. 2011;8(6):A134. http://www.cdc.gov/pcd/issues/2011/ nov/10-0234.htm.
40. Walsh JM, Salazar R, Nguyen TT, et al. Healthy colon, healthy life: a novel colorectal cancer screening intervention. Am J Prev Med. 2010;39(1):1-14.
41. Colorado Department of Public Health and Environment (CDPHE). Behavioral Risk Factor Surveillance System Survey Data. Denver, Colorado: Center for Health and Environmental Information and Statistics, Health Statistics Section, 2006, 2008.